After the publication of the new epidemic prevention regulations "Ten Articles of New China", residents all over the country set off a craze to build "small anti-virus medicine boxes at home". Even, the search volume of Lotus Qingwen increased by 2000 times year-on-year. What other drugs deserve as much attention as Lianhua Qingwen? Which listed companies produce these drugs? This paper will sort it out in detail.
Reference table of commonly used drugs for home treatment of infected people in COVID-19
Source: Comprehensive Group of Joint Prevention and Control Mechanism of Epidemic in novel coronavirus, the State Council.
Lotus Qingwen search volume increased by 2000 times year-on-year. Affected by the adjustment of epidemic prevention and control measures in many places, the sales of cold medicines, antipyretic and antitussive medicines, and antibacterial and anti-inflammatory medicines in JD Health increased significantly. According to the data of JD Health, the turnover of the above-mentioned drugs increased by 18 times in recent 7 days compared with that in 10. The top 5 drugs in number are Lianhua Qingwen, Putilan Xiaoyan Tablets, Compound Paracetamol Amine Tablets, Ibuprofen Sustained-release Capsules and Acetaminophen in turn. Among them, the search volume of Lotus Qingwen increased by 2000 times year-on-year.
Some traditional Chinese medicine prescriptions or proprietary Chinese medicines have been included in the diagnosis and treatment guidelines of COVID-19. According to the "New Diagnosis and Treatment Plan for Coronary Pneumonia (Trial Ninth Revision)" issued in March 2022, many prescriptions or Chinese patent medicines were included. According to the clinical effect, "three parties and three drugs" were screened out, namely Jinhua Qinggan Granule, Lianhua Qingwen Capsule and Xuebijing Injection, as well as Qingfei Jiedu Decoction, Huashi Jiedu Recipe and Xuanfei Jiedu Recipe, among which the Chinese patent medicines corresponding to Qingfei Jiedu Granule, Xuanfei Jiedu Recipe and Huashi Jiedu Recipe were quickly approved in 20021according to the new category of traditional Chinese medicine.
Suggestions on the use of traditional Chinese medicine in the ninth edition of COVID-19's diagnosis and treatment plan
Source: National Health Commission, state administration of traditional chinese medicine.
With the blessing of top-level design, the development of Chinese medicine has become a national strategy and a long-term issue. Opinions on Promoting Inheritance and Innovation of Traditional Chinese Medicine, Guiding Opinions on Medical Insurance Supporting Inheritance and Innovation of Traditional Chinese Medicine and Outline of the Tenth Five-Year Plan for the Development of Traditional Chinese Medicine released successively from 20 19-2022 have repeatedly reiterated the significance of inheritance and innovation and its role in disease prevention, and proposed to establish and improve a mechanism to include the expenses of traditional Chinese medicine in the scope of medical insurance payment according to regulations. The top-level design fully supports the innovation and development of traditional Chinese medicine on the basis of inheriting the precious wealth of ancestors, and the development of traditional Chinese medicine has become a national strategy and a long-term issue.
Top-level design supports relevant policies of Chinese medicine industry.
Source: State Administration of Pharmaceutical Products, China Government Network.
The important role of traditional Chinese medicine in epidemic prevention and control has been widely verified and recognized. From the end of last year to the beginning of this year, the Opinions on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine, the Guiding Opinions on Medical Insurance Supporting the Inheritance, Innovation and Development of Traditional Chinese Medicine and the Tenth Five-Year Development Plan of Traditional Chinese Medicine all positively affirmed that traditional Chinese medicine participated in the prevention and control work in an all-round way and played an important role in fighting the COVID-19 epidemic. Many provinces and places have successively issued Chinese medicine guidelines, diagnosis and treatment programs and recommended drugs. In this round of Omicron epidemic prevention and control, Chinese medicine has been deeply involved in all key areas and achieved results.
Sort out relevant listed companies
Treasure Island: According to 12 and 10, the state administration of traditional chinese medicine Expert Committee on Disease Prevention and Control of Traditional Chinese Medicine issued the Guide of Chinese Medicine Intervention for the Families of Infected People in COVID-19. Zhenbaodao Compound Qin Lan Oral Liquid, Shuanghuanglian Oral Liquid, Shengmai Drink and Xiaoer Zhike Syrup were included in the recommended drugs.
Guizhou Bailing: The company's exclusive Miao medicine "Kesuiting Syrup", the exclusive product specification "Xiaoer Chaigui Antipyretic Granule" and Xiaochaihu Granule were selected as recommended drugs for adults and children respectively. Lei's Liushen Pill (capsule) has also entered the Guide of Traditional Chinese Medicine Intervention for the Families of Infected People in COVID-19.
Kangyuan Pharmaceutical Co., Ltd.: The company's Quhan Qushi Granules began to be sold in the flagship store and Tmall of JD.COM Kangyuan Pharmaceutical Co., Ltd. on1October 24th and 25th. In response to an investor's question, he said that the company's overall production capacity can meet the current sales demand of cold-dispelling and dampness-removing granules, and the company is also expanding its production capacity through technical transformation and other measures to ensure that it can meet the future market demand.
Yisheng Pharmaceutical: The company's Qingkailing injection, Shengmai injection and ginseng have been included in the diagnosis and treatment plan of novel coronavirus for many times.
Hongri Pharmaceutical: Xuebijing Injection, the company's product, has been continuously included in the novel coronavirus Diagnosis and Treatment Plan (Trial 4th Edition-9th Edition) and recommended by state administration of traditional chinese medicine as an anti-epidemic Chinese medicine "Three Drugs and Three Parties".
Xiangxue Pharmaceutical Co., Ltd.: The company Yuekang 1 Chinese medicine decoction was included in the Chinese medicine intervention program for close contacts in novel coronavirus, Guangdong Province.
Huoxiang Zhengqi Oral Liquid (water, pills, tablets, capsules, granules and soft capsules): Yunnan Baiyao, Pien Tze Huang, Guangyuyuan, Tiansheng Pharmaceutical, Taiji Group, Buchang Pharmaceutical, etc.
Antiviral granules (oral liquid): Wohua Pharmaceutical, Kangyuan Pharmaceutical, Xiangxue Pharmaceutical, etc.
Shuangqing mixture: Li Sheng Pharmaceutical;
Jinhua Qinggan Granules: Tasly etc.
Lianhua Qingwen Capsule (granule): Yiling Pharmaceutical;
Fangfeng Tongsheng Pills (granules): Tongrentang, Foci Pharmaceutical, Jingxin Pharmaceutical, China Resources Sanjiu, Dong 'e Ejiao, Qianjin Pharmaceutical, Shenwei Pharmaceutical, Sunflower Pharmaceutical, Datang Pharmaceutical, Guangyuyuan Pharmaceutical, Zhendong Pharmaceutical, Wohua Pharmaceutical, Wayne Pharmaceutical, etc.
Jiuwei Notopterygium Granules (Pills): Sunflower Pharmaceutical, Jiuzhitang, Foci Pharmaceutical, etc.
Qingfei Xiaoyan Pill: Zhongxin Pharmaceutical;
Reduning injection: Kangyuan Pharmaceutical;
Xuebijing injection: Hongri Pharmaceutical;
Xingnaojing injection: Dali Pharmaceutical;
Angong Niuhuang Pills: Buchang Pharmaceutical, Baiyun Mountain, Tasly, Taiji Group, Pien Tze Huang, Jiuzhitang, Panlong Pharmaceutical, Jingxin Pharmaceutical and Guangyuyuan;
Su Hexiang Pills: Tong Ren Tang, Jiuzhitang, Foci Pharmaceutical, etc.
Shenmai injection: China Resources Sanjiu, Shenwei Pharmaceutical, Dali Pharmaceutical, etc.
Shengmai injection: Yisheng Pharmaceutical, China Resources Sanjiu, etc.
Shenfu injection: China Resources Sanjiu, etc.